158 related articles for article (PubMed ID: 2317754)
21. Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia.
Riccio I; Pota E; Marcarelli M; Affinita MC; Di Pinto D; Indolfi C; Del Regno N; Esposito M
Pediatr Med Chir; 2016 Nov; 38(3):118. PubMed ID: 28009137
[TBL] [Abstract][Full Text] [Related]
22. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
23. Osteonecrosis in children treated for acute leukemia.
Pediatric Hematology Working Group of the Czech Republic and Collaborators
Med Pediatr Oncol; 1999 Jun; 32(6):474-6. PubMed ID: 10358717
[No Abstract] [Full Text] [Related]
24. [Development of aseptic osteonecrosis during the treatment of acute lymphoblastic leukemia: review of the literature and author's own data].
Baranova OIu; Shirin AD; Falaleeva NA; Osmanov DSh
Ter Arkh; 2011; 83(7):26-32. PubMed ID: 21894748
[TBL] [Abstract][Full Text] [Related]
25. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
[TBL] [Abstract][Full Text] [Related]
26. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
[TBL] [Abstract][Full Text] [Related]
27. Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols.
van Atteveld JE; de Groot-Kruseman HA; Fiocco M; Lequin MH; Neggers SJCMM; Pluijm SMF; van der Sluis IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2021 Apr; 106(4):1198-1201. PubMed ID: 32646890
[No Abstract] [Full Text] [Related]
28. Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.
Karol SE; Janke LJ; Panetta JC; Ramsey LB; Cai X; Payton MA; Jenkins DA; Evans WE; Relling MV
PLoS One; 2019; 14(5):e0216328. PubMed ID: 31059548
[TBL] [Abstract][Full Text] [Related]
29. [Orthopedic diagnostic and therapeutic problems in avascular poststeroid necrosis of femur head in the course acute lymphoblastic leukemia--description of 3 cases].
Rapała K; Walczak P; Truszczyńska A
Chir Narzadow Ruchu Ortop Pol; 2010; 75(2):121-5. PubMed ID: 20695186
[TBL] [Abstract][Full Text] [Related]
30. Avascular necrosis after chemotherapy for haematological malignancy in childhood.
Salem KH; Brockert AK; Mertens R; Drescher W
Bone Joint J; 2013 Dec; 95-B(12):1708-13. PubMed ID: 24293604
[TBL] [Abstract][Full Text] [Related]
31. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
32. [Aseptic femur head osteonecrosis during treatment of acute lymphoblastic leukemia in the child].
Beguin A; Bertrand Y; Ourcival S; Foray P; Manel AM; Philippe N
Arch Pediatr; 1999 Sep; 6(9):971-4. PubMed ID: 10519032
[TBL] [Abstract][Full Text] [Related]
33. Avascular necrosis of bone following intensified steroid therapy for acute lymphoblastic leukaemia and high-grade malignant lymphoma.
Chan-Lam D; Prentice AG; Copplestone JA; Weston M; Williams M; Hutton CW
Br J Haematol; 1994 Jan; 86(1):227-30. PubMed ID: 8011540
[TBL] [Abstract][Full Text] [Related]
34. Avascular necrosis of bone following an intensified chemotherapy regimen including high dose steroids.
Thornton MJ; O'Sullivan G; Williams MP; Hughes PM
Clin Radiol; 1997 Aug; 52(8):607-12. PubMed ID: 9285421
[TBL] [Abstract][Full Text] [Related]
35. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
[TBL] [Abstract][Full Text] [Related]
36. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.
Browne EK; Zhou Y; Chemaitilly W; Panetta JC; Ness KK; Kaste SC; Cheng C; Relling MV; Pui CH; Inaba H
Cancer; 2018 Nov; 124(21):4248-4259. PubMed ID: 30358906
[TBL] [Abstract][Full Text] [Related]
37. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
38. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
[No Abstract] [Full Text] [Related]
40. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
